Prenatal Diagnosis, In Utero Management, and Perinatal Outcomes of Congenital Diaphragmatic Hernia

Felicia V LeMoine1, Sami Backley, Edgar Hernandez-Andrade

  • 1Division of Fetal Intervention, Department of Obstetrics, Gynecology and Reproductive Sciences, McGovern Medical School, University of Texas Health Science Center, Houston, Texas.

Insights

Congenital diaphragmatic hernia (CDH) is a rare birth defect. Prenatal diagnosis using ultrasound and interventions like FETO show promise for improving outcomes in severe cases, though more research is needed.

Area of Science:

  • Medical Genetics
  • Neonatal Surgery
  • Fetal Medicine

Background:

  • Congenital diaphragmatic hernia (CDH) affects 0.02%-0.03% of live births.
  • The causes of CDH are often complex and multifactorial.
  • Early detection and severity assessment are crucial for management.

Purpose of the Study:

  • To review the role of sonographic screening in CDH detection.
  • To evaluate the utility of lung-to-head ratio in predicting CDH severity.
  • To discuss the impact of fetal endoscopic tracheal occlusion (FETO) on CDH outcomes.

Main Methods:

  • Review of current literature on CDH diagnosis and management.
  • Analysis of sonographic screening efficacy and predictive measures.
  • Assessment of outcomes following prenatal interventions like FETO.

Main Results:

  • Sonography detects approximately 70% of CDH cases.
  • Lung-to-head ratio aids in predicting disease severity.
  • FETO has improved outcomes for severe left-sided CDH, but data for right-sided CDH and long-term effects are limited.

Conclusions:

  • Prenatal diagnosis of CDH is feasible through ultrasound.
  • Lung-to-head ratio is a valuable prognostic tool.
  • Further investigation is required for right-sided CDH and long-term outcomes after FETO.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
805
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
22
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
618